市場調查報告書

人體微生物的全球市場分析與預測:產品,疾病,用途,各地區

Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography

出版商 The Insight Partners 商品編碼 802185
出版日期 內容資訊 英文 150 Pages
訂單完成後即時交付
價格
Back to Top
人體微生物的全球市場分析與預測:產品,疾病,用途,各地區 Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography
出版日期: 2019年01月28日內容資訊: 英文 150 Pages
簡介

本報告提供全球人體微生物市場相關調查分析,總括性彙整市場概要,市場動態等相關考察,各產品,疾病,各用途,各地區市場分析,主要企業的簡介等資訊。

第1章 簡介

第2章 主要調查結果

第3章 人體微生物市場的狀況

  • 市場概要
  • 市場區隔
  • PEST分析

第4章 人體微生物市場:主要產業動態

  • 主要的推動市場的要素
  • 主要市場抑制因素
  • 主要市場機會
  • 臨床試驗
  • 影響分析

第5章 人體微生物市場:全球市場分析

  • 全球人體微生物市場概要
  • 全球人體微生物市場收益預測與分析
  • 市場定位/市場佔有率
  • 主要企業的業績
  • 專家的見解

第6章 全球人體微生物市場收益與預測:各產品

  • 概要
  • 產品市場收益與預測分析
  • 食品
  • 醫療食品
  • 益生菌
  • 益生元
  • 藥品
  • 診斷設備
  • 其他

第7章 全球人體微生物市場收益與預測:各疾病

  • 概要
  • 疾病市場收益與預測分析
  • 糖尿病
  • 癌症
  • 自體免疫疾病
  • 肥胖
  • 精神疾病
  • 其他

第8章 全球人體微生物市場收益與預測:各用途

  • 概要
  • 用途市場收益與預測分析
  • 診斷
  • 治療

第9章 北美的人體微生物市場收益與預測:各國分析

第10章 歐洲的人體微生物市場收益與預測:各國分析

第11章 亞太地區的人體微生物市場收益與預測:各國分析

第12章 中東/非洲的人體微生物市場收益與預測:各國分析

第13章 中南美的人體微生物市場收益與預測:各國分析

第14章 產業狀況

第15章 人體微生物市場:主要企業簡介

  • ENTEROME
  • MERCK & CO., INC.
  • MICROBIOME THERAPEUTICS, LLC
  • REBIOTIX INC.
  • YAKULT HONSHA CO., LTD.
  • OSEL INC.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DUPONT

第16章 附錄

目錄
Product Code: TIPBT00002233

The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025.

The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. However, the strict government guidelines is the major concern in the human microbiome market. The strict government guidelines are intended to hamper the market to an extent. The advancements in science and technology made the scientists excited about the potential and potency of fecal matter and the microbes in it. The cell-based therapies found a novel paradigm in drug development, a regulatory framework that reports safety and bio containment issues should be established to minimize adverse events and environmental release of engineered organisms. In recent years, for drug discovery the microbiota plays an important role in the efficacy of therapeutic compounds. There is a new phenomenon in the globe. It is the human gut microbiome and the role it may play in the future of human health. Recently various reports have indicated that the human gut microbiome may be implicated in health conditions such as obesity, metabolism, diabetes, immunity and autism.

The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.

The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics. In 2017, therapeutics segment held the largest share of the market, by application. Moreover, the therapeutics segment is expected to grow at the fastest rate during the coming years owing to the increase in digestive problems, increase in the drug-related side effects, and development of therapies for chronic diseases like cancer.

Some of the major primary and secondary sources included in the report for the human microbiome market are National Cancer Institute, National Health Service, World Health Organization, Food and Drug Administration, Public Health England, and Health Protection Agency among others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. SCOPE OF STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. HUMAN MICROBIOME MARKET LANDSCAPE

  • 3.1. MARKET OVERVIEW
  • 3.2. MARKET SEGMENTATION
    • 3.2.1. Human Microbiome Market - By Product
    • 3.2.2. Human Microbiome Market - By Disease
    • 3.2.3. Human Microbiome Market - By Application
    • 3.2.4. Human Microbiome Market - By Region
      • 3.2.4.1. By Country
  • 3.3. PEST ANALYSIS
    • 3.3.1. North America - PEST Analysis
    • 3.3.2. Europe - PEST Analysis
    • 3.3.3. Asia Pacific - PEST Analysis
    • 3.3.4. Middle East and Africa - PEST Analysis
    • 3.3.5. South and Central America- PEST Analysis

4. HUMAN MICROBIOME MARKET - KEY INDUSTRY DYNAMICS

  • 4.1. KEY MARKET DRIVERS
  • 4.2. KEY MARKET RESTRAINTS
  • 4.3. KEY MARKET OPPORTUNITIES
  • 4.4. CLINICAL TRIALS
  • 4.5. IMPACT ANALYSIS

5. HUMAN MICROBIOME MARKET - GLOBAL ANALYSIS

  • 5.1. GLOBAL HUMAN MICROBIOME MARKET OVERVIEW
  • 5.2. GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 5.3. MARKET POSITIONING/MARKET SHARE
  • 5.4. PERFORMANCE OF KEY PLAYERS
  • 5.5. EXPERT OPINIONS

6. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT

  • 6.1. OVERVIEW
  • 6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 6.3. FOODS MARKET
    • 6.3.1. Overview
    • 6.3.2. Foods Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.4. MEDICAL FOODS MARKET
    • 6.4.1. Overview
    • 6.4.2. Medical Foods Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.5. PROBIOTICS MARKET
    • 6.5.1. Overview
    • 6.5.2. Probiotics Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.6. PREBIOTICS MARKET
    • 6.6.1. Overview
    • 6.6.2. Prebiotics Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.7. DRUGS MARKET
    • 6.7.1. Overview
    • 6.7.2. Drugs Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.8. DIAGNOSTIC DEVICES MARKET
    • 6.8.1. Overview
    • 6.8.2. Diagnostic Devices Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.9. OTHER PROBIOTIC SUPPLEMENTS MARKET
    • 6.9.1. Overview
    • 6.9.2. Other Probiotic Supplements Market Revenue Forecasts and Analysis (US$ Mn)

7. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE

  • 7.1. OVERVIEW
  • 7.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 7.3. DIABETES MARKET
    • 7.3.1. Overview
    • 7.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.4. CANCER MARKET
    • 7.4.1. Overview
    • 7.4.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.5. AUTOIMMUNE DISORDERS MARKET
    • 7.5.1. Overview
    • 7.5.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.6. OBESITY MARKET
    • 7.6.1. Overview
    • 7.6.2. Obesity Market Revenue Forecasts and Analysis (US$ Mn
  • 7.7. MENTAL DISORDERS MARKET
    • 7.7.1. Overview
    • 7.7.2. Mental Disorders Market Revenue Forecasts and Analysis (US$ Mn
  • 7.8. OTHER DISEASES MARKET
    • 7.8.1. Overview
    • 7.8.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)

8. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 8.3. DIAGNOSTICS MARKET
    • 8.3.1. Overview
    • 8.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
  • 8.4. THERAPEUTICS MARKET
    • 8.4.1. Overview
    • 8.4.2. Therapeutics Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 9.1. NORTH AMERICA HUMAN MICROBIOME MARKET OVERVIEW
  • 9.2. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 9.3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 9.4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 9.5. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 9.6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 9.7. US MARKET OVERVIEW
    • 9.7.1. US Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.7.2. US Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.7.3. US Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 9.8. CANADA MARKET OVERVIEW
    • 9.8.1. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.8.2. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.8.3. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 9.9. MEXICO MARKET OVERVIEW
    • 9.9.1. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.9.2. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.9.3. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 10.1. EUROPE HUMAN MICROBIOME MARKET OVERVIEW
  • 10.2. EUROPE HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 10.3. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 10.4. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 10.5. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 10.6. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 10.7. UK MARKET OVERVIEW
    • 10.7.1. UK Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.7.2. UK Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.7.3. UK Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 10.8. GERMANY MARKET OVERVIEW
    • 10.8.1. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.8.2. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.8.3. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 10.9. FRANCE MARKET OVERVIEW
    • 10.9.1. France Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.9.2. France Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.9.3. France Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn

11. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 11.1. ASIA PACIFIC HUMAN MICROBIOME MARKET OVERVIEW
  • 11.2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 11.3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 11.4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 11.5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 11.6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 11.7. JAPAN MARKET OVERVIEW
    • 11.7.1. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.7.2. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.7.3. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 11.8. CHINA MARKET OVERVIEW
    • 11.8.1. China Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.8.2. China Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.8.3. China Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 11.9. INDIA MARKET OVERVIEW
    • 11.9.1. India Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.9.2. India Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.9.3. India Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 12.1. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET OVERVIEW
  • 12.2. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 12.3. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 12.4. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 12.5. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 12.6. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 12.7. SOUTH AFRICA MARKET OVERVIEW
    • 12.7.1. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.7.2. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.7.3. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 12.8. SAUDI ARABIA MARKET OVERVIEW
    • 12.8.1. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.8.2. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.8.3. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 12.9. UAE MARKET OVERVIEW
    • 12.9.1. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.9.2. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.9.3. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 13.1. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET OVERVIEW
  • 13.2. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 13.3. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 13.4. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 13.5. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 13.6. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 13.7. BRAZIL MARKET OVERVIEW
    • 13.7.1. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 13.7.2. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 13.7.3. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

14. INDUSTRY LANDSCAPE

  • 14.1. ORGANIC GROWTH STRATEGIES
    • 14.1.1. New Product Launches
    • 14.1.2. Marketing & Promotional Activities
  • 14.2. INORGANIC GROWTH STRATEGIES
    • 14.2.1. Partnerships, Collaborations, and Joint Ventures
    • 14.2.2. Mergers & Acquisitions

15. HUMAN MICROBIOME MARKET, KEY COMPANY PROFILES

  • 15.1. ENTEROME
    • 15.1.1. Key Facts
    • 15.1.2. Business Description
    • 15.1.3. Financial Overview
    • 15.1.4. Product Portfolio
    • 15.1.5. Product Pipeline
    • 15.1.6. SWOT Analysis
    • 15.1.7. Key Developments
  • 15.2. MERCK & CO., INC.
    • 15.2.1. Key Facts
    • 15.2.2. Business Description
    • 15.2.3. Financial Overview
    • 15.2.4. Product Portfolio
    • 15.2.5. Product Pipeline
    • 15.2.6. SWOT Analysis
    • 15.2.7. Key Developments
  • 15.3. MICROBIOME THERAPEUTICS, LLC
    • 15.3.1. Key Facts
    • 15.3.2. Business Description
    • 15.3.3. Financial Overview
    • 15.3.4. Product Portfolio
    • 15.3.5. Product Pipeline
    • 15.3.6. SWOT Analysis
    • 15.3.7. Key Developments
  • 15.4. REBIOTIX INC.
    • 15.4.1. Key Facts
    • 15.4.2. Business Description
    • 15.4.3. Financial Overview
    • 15.4.4. Product Portfolio
    • 15.4.5. Product Pipeline
    • 15.4.6. SWOT Analysis
    • 15.4.7. Key Developments
  • 15.5. YAKULT HONSHA CO., LTD.
    • 15.5.1. Key Facts
    • 15.5.2. Business Description
    • 15.5.3. Financial Overview
    • 15.5.4. Product Portfolio
    • 15.5.5. Product Pipeline
    • 15.5.6. SWOT Analysis
    • 15.5.7. Key Developments
  • 15.6. OSEL INC.
    • 15.6.1. Business Description
    • 15.6.2. Financial Overview
    • 15.6.3. Product Portfolio
    • 15.6.4. Product Pipeline
    • 15.6.5. SWOT Analysis
    • 15.6.6. Key Developments
  • 15.7. Vedanta Biosciences, Inc.
    • 15.7.1. Key Facts
    • 15.7.2. Business Description
    • 15.7.3. Financial Overview
    • 15.7.4. Product Portfolio
    • 15.7.5. Product Pipeline
    • 15.7.6. SWOT Analysis
    • 15.7.7. Key Developments
  • 15.8. Metabiomics Corporate
    • 15.8.1. Key Facts
    • 15.8.2. Business Description
    • 15.8.3. Financial Overview
    • 15.8.4. Product Portfolio
    • 15.8.5. Product Pipeline
    • 15.8.6. SWOT Analysis
    • 15.8.7. Key Developments
  • 15.9. Synthetic Biologics, Inc.
    • 15.9.1. Key Facts
    • 15.9.2. Business Description
    • 15.9.3. Financial Overview
    • 15.9.4. Product Portfolio
    • 15.9.5. Product Pipeline
    • 15.9.6. SWOT Analysis
    • 15.9.7. Key Developments
  • 15.10. DUPONT
    • 15.10.1. Key Facts
    • 15.10.2. Business Description
    • 15.10.3. Financial Overview
    • 15.10.4. Product Portfolio
    • 15.10.5. Product Pipeline
    • 15.10.6. SWOT Analysis
    • 15.10.7. Key Developments

16. APPENDIX

  • 16.1. ABOUT THE INSIGHT PARTNERS
  • 16.2. GLOSSARY OF TERMS
  • 16.3. RESEARCH METHODOLOGY
Back to Top